KINIKSA PHARMACEUTICALS INTL

Ticker: KNSA CUSIP: G52694109 Class: Common Stock

RICE HALL JAMES & ASSOCIATES, LLC's Holding History (CIK: 0001230765)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 596,431 Value ($000) $24,603 Avg Close $40.11 Range $35.20 - $44.42

Q3 2025

Shares 577,822 Value ($000) $22,437 Avg Close $32.49 Range $26.27 - $39.00

Q2 2025

Shares 638,233 Value ($000) $17,660 Avg Close $25.46 Range $18.25 - $30.69

Q1 2025

Shares 624,545 Value ($000) $13,871 Avg Close $20.58 Range $17.82 - $24.31

Q4 2024

Shares 642,752 Value ($000) $12,714 Avg Close $22.82 Range $19.47 - $28.15

Q3 2024

Shares 649,630 Value ($000) $16,234 Avg Close $24.36 Range $17.38 - $27.92

Q2 2024

Shares 600,630 Value ($000) $11,214 Avg Close $18.73 Range $16.56 - $20.52

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	596,431	$24,603	$40.11	$35.20 - $44.42
Q3 2025	577,822	$22,437	$32.49	$26.27 - $39.00
Q2 2025	638,233	$17,660	$25.46	$18.25 - $30.69
Q1 2025	624,545	$13,871	$20.58	$17.82 - $24.31
Q4 2024	642,752	$12,714	$22.82	$19.47 - $28.15
Q3 2024	649,630	$16,234	$24.36	$17.38 - $27.92
Q2 2024	600,630	$11,214	$18.73	$16.56 - $20.52